Neogen Balance Sheet
NASDAQ: NEOGHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Neogen financial position
At the end of fiscal 2026, Neogen reported total assets of $3.35 billion, down 2.8% from a year earlier against total liabilities of $1.25 billion. Shareholders' equity stood at $2.09 billion, or 62.5% of assets. The company held $185.5 million in cash and equivalents against $793.7 million of debt, a net debt position of $608.2 million.
The current ratio (current assets divided by current liabilities) was 3.82, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.38.
Summary generated from market data by MetaCap's automated system. Methodology
Neogen balance sheet (annual)
| Fiscal year (USD) | FY 20262026-05-31 | FY 20252025-05-31 | FY 20242024-05-31 | FY 20232023-05-31 | FY 20222022-05-31 | FY 20212021-05-31 | FY 20202020-05-31 | FY 20192019-05-31 | FY 20182018-05-31 | FY 20172017-05-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 185.50M | 129.00M | 170.61M | 163.24M | 44.47M | 75.60M | 66.27M | 41.69M | 83.07M | 77.57M |
| Short-Term Investments | — | 0 | 325.00K | 82.33M | 336.58M | 305.49M | 277.40M | 225.84M | 127.74M | 66.07M |
| Receivables | 146.80M | 153.40M | 173.00M | 153.25M | 99.67M | 91.82M | 84.68M | 82.58M | 79.09M | 68.58M |
| Inventory | 144.30M | 190.80M | 189.27M | 133.81M | 122.31M | 100.70M | 95.05M | 85.99M | 76.00M | 73.14M |
| Total Current Assets | 604.60M | 576.90M | 589.23M | 585.93M | 626.80M | 591.45M | 537.41M | 449.53M | 375.79M | 292.96M |
| Property, Plant & Equipment | 329.80M | 339.10M | 277.10M | 198.75M | 110.58M | 100.45M | 78.67M | 74.85M | 73.07M | 61.75M |
| Goodwill | 1.05B | 1.06B | 2.14B | 2.14B | 142.70M | 131.48M | 110.34M | 103.62M | 99.56M | 104.76M |
| Intangible Assets | 1.32B | 1.41B | 1.51B | 1.61B | 92.11M | 76.77M | 51.36M | 52.10M | 54.66M | 54.62M |
| Total Assets | 3.35B | 3.44B | 4.55B | 4.55B | 992.93M | 920.19M | 797.18M | 695.74M | 618.01M | 528.41M |
| Accounts Payable | 79.10M | 79.60M | 83.06M | 76.67M | 34.61M | 23.90M | 25.65M | 19.06M | 20.75M | 16.24M |
| Short-Term Debt | 0 | 19.30M | 2.45M | 900.00M | — | — | — | — | — | — |
| Total Current Liabilities | 158.20M | 174.00M | 154.32M | 145.47M | 77.84M | 53.60M | 48.49M | 38.25M | 38.69M | 36.00M |
| Long-Term Debt | 793.70M | 874.80M | 888.39M | 885.44M | 0 | — | — | — | — | — |
| Total Liabilities | 1.25B | 1.37B | 1.40B | 1.42B | 105.56M | 79.81M | 72.00M | 57.84M | 57.83M | 56.65M |
| Shareholders' Equity | 2.09B | 2.07B | 3.14B | 3.13B | 887.37M | 840.38M | 725.18M | 637.90M | 560.17M | 471.61M |
| Retained Earnings | -544.30M | -536.40M | 555.62M | 565.04M | 587.91M | 539.60M | 478.72M | 419.25M | 359.07M | 295.93M |
| Total Debt | 793.70M | 894.10M | 890.84M | 1.79B | 0 | — | — | — | — | — |
| Net Cash (Debt) | -608.20M | -765.10M | -719.90M | -1.54B | 381.05M | 381.09M | 343.67M | 267.52M | 210.81M | 143.63M |
| Shares Outstanding | 217.70M | 217.00M | 217.04M | 216.25M | 107.80M | 107.47M | 105.89M | 52.22M | 51.74M | 50.93M |
This table shows 10 annual periods of Neogen's balance sheet, from FY 2026 back to FY 2017, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow NEOG's reporting calendar. What is a balance sheet?